Home Online Features FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
Hand-out
Press Releases
NS Pharma, Inc.  
March 10, 2025

FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment

PARAMUS, N.J., March 10, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that acceptance has been received by Capricor

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social